Moneycontrol PRO
HomeNewsIndiaMaharashtra reports eight new Omicron infections, tally rises to 40          

Maharashtra reports eight new Omicron infections, tally rises to 40          

Out of these new cases, six have been found positive in Pune, one each in Mumbai and Kalyan Dombivali.

December 17, 2021 / 21:27 IST
Representative image

Representative image

Maharashtra on December 17 reported eight new cases of the new strain Omicron, as the state's tally reached 40. Out of these new cases, six have been found positive in Pune, one each in Mumbai and Kalyan Dombivali.

“As per the report given by National Institute of Virology today, eight more patients were found to be infected with Omicron in the state,” the Maharashtra Health Department has said.

So far, a total of 40 patients have been infected with the Omicron virus, it added.

Maharashtra on Thursday reported 877 new coronavirus positive cases, and 19 fatalities, which took its infection tally to 66,46,938 and death toll to 1,41,317, the state health department said.

On Wednesday, the state had reported 925 COVID-19 cases and 10 fatalities. A total of 632 patients were discharged during the day, taking the overall recovery count to 64,95,249.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Maharashtra's COVID-19 recovery rate is 97.72 percent, while the fatality rate stands at 2.12 percent.

The World Health Organization (WHO), which had classified Omicron as a 'variant of concern', recently said that it is spreading at a rate not seen with any previous strain.

A new variant of COVID-19 was first reported to the World Health Organisation (WHO) from South Africa on November 25. As per the WHO, the first known confirmed B.1.1.529 infection was from a specimen collected on November 9 this year.

On November 26, the WHO named the new COVID-19 variant B.1.1.529, which has been detected in South Africa, as 'Omicron'. The WHO has classified Omicron as a 'variant of concern'.

PTI
first published: Dec 17, 2021 09:27 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347